Dayton Clinical Oncology Program

代顿临床肿瘤学项目

基本信息

  • 批准号:
    8790597
  • 负责人:
  • 金额:
    $ 100.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-01 至 2019-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Dayton Clinical Oncology Program (DCOP) was incorporated in the State of Ohio in 1982 as a non-profit 501 C-3 corporation. A Consortium Agreement was established between DCOP, the Dayton Area adult hospitals, and Wright State University (WSU). A governing board was established, and corporate bylaws were developed. Currently, DCOP has an elected Board of Directors with Howard M. Gross, M.D., DCOP Principal investigator, as Chairperson of the Board, Stuart Marl, M.D., Associate Principal Investigator, as Vice Chairperson, Sidney J. Pinkus, MBA, Chief Executive Officer of DCOP, as President of the Board, and 15 other Directors representing the 12 member hospitals, WSU, and at-large community members of our service area. The Board meets semi-annually to review budget reports and program activities. Since 1982, DCOP has successfully applied for and received funding from NCl as a CCOP. We are currently seeking continued funding through the five fiscal year period ending May 31, 2019 as an N-CORP. Our current staff includes 17 Oncology Research Nurses funded by our member hospitals, and 18 office staff funded by the grant, including directors for quality, regulatory, research projects, and education, regulatory coordinator, data coordinators, research coordinators, administrative assistant, and research associate. Our current active physician co-investigators total 78, representing our 12 hospitals and various specialties including oncology, radiation therapy, urology, surgery, gynecology, pulmonary and gastroenterology. WSU has been providing personnel, payroll, and accounting services support through a sub-contracting relationship established on December 23, 2001, when the grant was transferred from former fiscal agent Kettering Medical Center to DCOP. DCOP has continued as the grantee organization since that date.
描述(由申请人提供):代顿临床肿瘤学计划(DCOP)于1982年在俄亥俄州成立,是一家非营利性的501C-3公司。DCOP、代顿地区成人医院和莱特州立大学(WSU)之间建立了一项联盟协议。成立了管理委员会,制定了公司章程。目前,DCOP有一个由选举产生的董事会,DCOP首席调查员Howard M.Gross医学博士担任董事会主席,副首席调查员Stuart Marl医学博士担任副主席,DCOP首席执行官Sidney J.Pinkus MBA担任董事会主席,其他15名董事代表我们服务领域的12家成员医院、西澳州立大学和广大社区成员。委员会每半年举行一次会议,审查预算报告和方案活动。自1982年以来,DCOP以CCOP的身份成功申请并获得了NCL的资助。我们目前正在寻求在截至2019年5月31日的五个财年期间作为N-Corp继续提供资金。我们目前的工作人员包括17名由我们的成员医院资助的肿瘤学研究护士,以及18名由赠款资助的办公室工作人员,包括质量、监管、研究项目和教育主任、监管协调员、数据协调员、研究协调员、行政助理和研究助理。我们目前的现役医生协查人员共有78人,代表我们的12家医院和不同的专业,包括肿瘤科、放射治疗、泌尿科、外科、妇科、肺科和胃肠科。WSU一直通过2001年12月23日建立的分包关系提供人事、工资和会计服务支持,当时赠款从前财政代理凯特琳医疗中心转移到DCOP。DCOP自该日起继续作为受赠人组织。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Howard M Gross其他文献

Howard M Gross的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Howard M Gross', 18)}}的其他基金

Dayton Clinical Oncology Program
代顿临床肿瘤学项目
  • 批准号:
    9320521
  • 财政年份:
    2014
  • 资助金额:
    $ 100.5万
  • 项目类别:
Dayton Clinical Oncology Program
代顿临床肿瘤学项目
  • 批准号:
    9770709
  • 财政年份:
    2014
  • 资助金额:
    $ 100.5万
  • 项目类别:
Dayton Clinical Oncology Program
代顿临床肿瘤学项目
  • 批准号:
    10673173
  • 财政年份:
    2014
  • 资助金额:
    $ 100.5万
  • 项目类别:
Dayton Clinical Oncology Program
代顿临床肿瘤学项目
  • 批准号:
    9117475
  • 财政年份:
    2014
  • 资助金额:
    $ 100.5万
  • 项目类别:
Dayton Clinical Oncology Program
代顿临床肿瘤学项目
  • 批准号:
    10457291
  • 财政年份:
    2014
  • 资助金额:
    $ 100.5万
  • 项目类别:
Dayton Clinical Oncology Program
代顿临床肿瘤学项目
  • 批准号:
    10225452
  • 财政年份:
    2014
  • 资助金额:
    $ 100.5万
  • 项目类别:
DAYTON CLINICAL ONCOLOGY PROGRAM
代顿临床肿瘤学项目
  • 批准号:
    6375669
  • 财政年份:
    1983
  • 资助金额:
    $ 100.5万
  • 项目类别:
DAYTON CLINICAL ONCOLOGY PROGRAM
代顿临床肿瘤学项目
  • 批准号:
    6547424
  • 财政年份:
    1983
  • 资助金额:
    $ 100.5万
  • 项目类别:
DAYTON CLINICAL ONCOLOGY PROGRAM
代顿临床肿瘤学项目
  • 批准号:
    6512440
  • 财政年份:
    1983
  • 资助金额:
    $ 100.5万
  • 项目类别:
Dayton Clinical Oncology Program
代顿临床肿瘤学项目
  • 批准号:
    8296026
  • 财政年份:
    1983
  • 资助金额:
    $ 100.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 100.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 100.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 100.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 100.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 100.5万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 100.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 100.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 100.5万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 100.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 100.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了